These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7341293)

  • 21. Three decades of human monoclonal antibodies: past, present and future developments.
    Steinitz M
    Hum Antibodies; 2009; 18(1-2):1-10. PubMed ID: 19478393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for weak monoclonal antibodies in hybridoma technology.
    Leickt L; Grubb A; Ohlson S
    J Mol Recognit; 1998; 11(1-6):114-6. PubMed ID: 10076820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.
    Majidi J; Hassan ZM
    Hum Antibodies; 2003; 12(3):93-8. PubMed ID: 14646037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific human antibodies from mice comprising four distinct genetic modifications.
    Lonberg N; Taylor LD; Harding FA; Trounstine M; Higgins KM; Schramm SR; Kuo CC; Mashayekh R; Wymore K; McCabe JG
    Nature; 1994 Apr; 368(6474):856-9. PubMed ID: 8159246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of the hybridoma principle in 1968-69 immortalization of the specific antibody-producing cell by fusion with a lymphoma cell.
    Sinkovics JG
    J Med; 1985; 16(5-6):509-24. PubMed ID: 3868685
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoclonal antibodies in clinical immunology.
    Sevier ED; David GS; Martinis J; Desmond WJ; Bartholomew RM; Wang R
    Clin Chem; 1981 Nov; 27(11):1797-806. PubMed ID: 7028317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
    Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Storage and reconstruction of hybridomas producing monoclonal antibodies against viral antigens].
    Malakhova IV; Zorin EV; Novokhatskiĭ AS
    Mol Gen Mikrobiol Virusol; 1985 Mar; (3):41-4. PubMed ID: 3842746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary report on the production of hybridoma cell lines secreting monoclonal antibodies against adult worm antigens of Paragonimus westermani].
    Huang SR
    Zhonghua Yi Xue Za Zhi; 1985 Jan; 65(1):41-3. PubMed ID: 3919906
    [No Abstract]   [Full Text] [Related]  

  • 30. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p32, a platelet autoantigen recognized by an SLE-derived autoantibody that inhibits platelet aggregation.
    Xu H; Frojmovic MM; Wong T; Rauch J
    J Autoimmun; 1995 Feb; 8(1):97-119. PubMed ID: 7734040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Production and clinical applications of monoclonal antibodies against measles virus and HBs antigen].
    Togashi T; Kuwashima S; Takebayashi T; Ozutsumi K; Kato T; Nakamura S
    Rinsho Byori; 1983 Mar; 31(3):246-53. PubMed ID: 6865034
    [No Abstract]   [Full Text] [Related]  

  • 33. [Production and characterization of monoclonal antibodies with P1 specificity].
    Vezon G; Piquet Y; Chevaleyre J; Sondag-Thull D; François-Gérard C; Cartron JP
    C R Seances Soc Biol Fil; 1986; 180(1):57-63. PubMed ID: 2943371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of recombinant human anti-HBs Fab antibodies.
    Maeda F; Takekoshi M; Nagatsuka Y; Aotsuka S; Tsukahara M; Ohshima A; Kido I; Ono Y; Ihara S
    J Virol Methods; 2005 Aug; 127(2):141-7. PubMed ID: 15896855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody engineering, a strategy for the development of monoclonal antibodies.
    Schönherr OT; Houwink EH
    Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies against tumour-associated antigens: mycoplasma as a major technical obstacle and its possible circumvention by azaserine selection medium.
    Karsten U; Rudolph M
    Arch Geschwulstforsch; 1985; 55(5):305-10. PubMed ID: 4062491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison and critical analysis of robotized technology for monoclonal antibody high-throughput production.
    Chiarella P; Leuener M; Fasci C; de Marco A; Santini MP; Fazio VM; Sawyer AM
    Biotechnol Prog; 2011; 27(2):571-6. PubMed ID: 21425250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of antibody against horseradish peroxidase using hybridoma technology.
    Asadi A; Pourfathollah AA; Mahdavi M; Eftekharian MM; Moazzeni SM
    Hum Antibodies; 2008; 17(3-4):73-8. PubMed ID: 19029664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The murine plasma cell antigen PC-1: purification and partial amino acid sequence.
    Stearne PA; van Driel IR; Grego B; Simpson RJ; Goding JW
    J Immunol; 1985 Jan; 134(1):443-8. PubMed ID: 3917281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity technique.
    Yari F; Sareh S; Sadri A; Sharifi Z; Najafi F
    Hum Antibodies; 2009; 18(3):119-22. PubMed ID: 19729806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.